Press Release: Cesca : ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices
RANCHO CORDOVA, Calif., Sept. 25, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and...
Read full article »
Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases.
Read more